Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 305-729-0 | CAS number: 95009-01-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- March 21, 1995 - May 21, 1995.
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- other: USA EPA test
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- other: Principles and Method of Toxicology
- Version / remarks:
- 1994 / Hayes, A.W.
- GLP compliance:
- no
- Test type:
- standard acute method
Test material
- Reference substance name:
- Sodium [4-[[dihydroxy[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]benzenesulphonato(3-)]cuprate(1-)
- EC Number:
- 305-729-0
- EC Name:
- Sodium [4-[[dihydroxy[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]benzenesulphonato(3-)]cuprate(1-)
- Cas Number:
- 95009-01-1
- Molecular formula:
- C18H9CuN6O10S.Na
- IUPAC Name:
- Reaction products of diazotized 4-aminobenzenesulfonic acid coupled with resorcinol subsequently coupled with diazotised 2-amino-4,6-dinitrophenol, copper (2+) complexes, sodium salts
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Name of test material (as cited in study report): Everlan Brown EFR
- Substance type: Powder
- Composition of test material, percentage of components: -
- Sample is produced in 2004
- Storage condition of test material: Ambient
Constituent 1
- Specific details on test material used for the study:
- - Name of test material: Everlan Brown EFR Dye Powder
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- - Source: Laboratory Animal Center, National Taiwan University.
- Age at study initiation: about 5 week old
- Housing: in cage
- Diet: ad libitum
- Water: ad libitum
- Temperature (°C): 25 ± 1 °C
- Humidity (%): 50-70 %
- Photoperiod: 12-hrs dark / 12-hrs light cycle
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Doses:
- 5000 mg/kg
- No. of animals per sex per dose:
- 5 male and 5 female
- Control animals:
- yes
- Details on study design:
- Intoxicant symptoms, symptom occurrence, and death are recorded 1/2, 1, 2, and 4 hours after dosing. From the second day to 14th day, all rats are inspected once daily.
Treated rats are necropsied and all gross pathological changes were recorded.
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
Any other information on results incl. tables
Table 1. Acute oral toxicity of Everlan Brown EFR Dye Powder in rats
Dose (mg/kg) |
Mortality for 14 days |
||
Male |
Female |
Total |
|
Control 5000 |
0/5 0/5 |
0/5 0/5 |
0/10 0/10 |
Table 2. The time course of death caused by the oral administration of Everlan Brown EFR Dye Powder
Sex |
Days after administration |
||||||||
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
14 |
|
Male Female |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
0 0 |
Table 3. Body weight change of rats gavaged with Everlan Brown EFR Dye Powder
Sex |
Dose mg/kg |
Days after administration |
||
0 |
7 |
14 |
||
Male |
Control 5000 |
209.0±10.1 204.4±11.2* |
232.4±12.8 224.6±11.5* |
261.0±12.9 253.0±13.7* |
Female |
Control 5000 |
208.4±11.6 201.8±11.5* |
230.0±10.7 222.8±11.3* |
262.2±12.4 250.6±11.4* |
* Significant difference between control and treated group
Table 4. Percentages of body weight change of rats gavaged with Everlan Brown EFR Dye Powder by F-test
Sex |
Dose mg/kg |
Days after administration |
|
7 |
14 |
||
Male |
Control 5000 |
11.2±1.3 9.9±0.8 |
24.9±1.1 23.8±2.4 |
Female |
Control 5000 |
10.4±2.0 10.4±1.4 |
25.4±2.7 24.2±1.7 |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- According to recommend USA EPA test and good laboratory practice (GLP) guidelines, the LD50 of Everlan Brown EFR Dye Powder was greater than 5000 mg/kg. Therefore, Everlan Brown EFR Dye Powder was not met a category based on GHS criteria.
- Executive summary:
This test using the procedures outlined in the TACTRI for TXD45ao which is based on the USA EPA test and "Principles and Method of Toxicology (1994)".Wistar rats were administered by gavage with Everlan Brown EFR Dye Powder at a fixed dose of 5,000 mg/kg. At the end of experiment, all animals tolerated the test article well with increasing body weights and no mortality or gross lesions findings reported. The acute oral LD50 of Everlan Brown EFR Dye Powder was greater than 5,000 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.